Ashley Nash Joins Workforce Genetics to Lead Recruiting and Employer Branding Practice
Ashley Nash has joined Workforce Genetics as the Director of Recruiting and Talent Engagement. Ashley will oversee recruiting, client success, HR consulting, and operational strategy to deliver an exceptional experience to our clients across the Biohealth Capital Region.
Ashley brings extensive experience in recruiting, consulting, and employer branding as well as a passion for science. “I’m excited to combine my curiosity for science with my background in recruiting. Chris has a clear vision for Workforce Genetics, and I’m looking forward to joining him on that journey.”
Prior to joining Workforce Genetics, Ashley managed recruiting and employer branding for Howard Hughes Medical Institute (HHMI), a leading private research philanthropy. In addition to her work at HHMI, she has also recruited for various other industries; including healthcare, management consulting, and technology.
“Our clients are facing some of the toughest recruiting and workforce challenges driven by industry growth, low unemployment, skills shortages and emerging new technologies. They are looking to us for new solutions that deliver results and help them compete for talent,” shared Workforce Genetics CEO, Chris Frew. “Ashley’s experience in leading organizations through these challenges will be a tremendous asset for our clients and allow us to continue to grow our recruiting and employer branding practice as an industry leader in this field.”
Ashley completed her undergraduate education at University of Michigan, with a Bachelor of Science in Movement Science. She also graduated with a Master of Management and Strategic Leadership from Walsh College. She holds dual certifications from SHRM and AIRS for HR and Recruiting, respectively. In her free time, she enjoys golf, yoga, and spending time with her husband, Robert, and their Labrador, Molly.
For more on Workforce Genetics visit www.workforcegenetics.com or contact Ashley directly at ‘ashley @ workforcegenetics.com’
Latest posts by Chris Frew (see all)
- CRB Welcomes Alex Moore as a Senior Biopharma Specialist in the Maryland Office - November 23, 2020
- Merck to Acquire Maryland-based OncoImmune’s Promising COVID-19 Drug in $425 Million Deal - November 23, 2020
- WuXi Advanced Therapies Expands Philadelphia Campus with New State-of-The-Art Testing Laboratory - November 20, 2020